Please Wait

Applying Filters...

Zazole
CEP/COS
Table View

Top Pharma Companies & Drugs in 2024: Merck’s Keytruda maintains top spot as Novo’s semaglutide nips at its heels

Data Compilation
#PharmaFlow

Pipeline Prospector March 2025: Trump’s FDA overhaul spooks biotech stocks; Roche, AbbVie, Novo ink obesity drug deals

Stock Recap
#PipelineProspector

Zazole

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

12 API Suppliers, 6 USDMF, 2 CEP/COS, 1 EU WC, 3 NDC API, 5 Listed Suppliers, $ API Reference Price

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

12 FDF Dossiers, 10 FDA Orange Book, 1 Canada, 1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;VAGINAL - 0.4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUPPOSITORY;VAGINAL - 80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;VAGINAL - 0.8% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;VAGINAL - 0.8%

RELATED EXCIPIENT COMPANIES

3 Nanjing Well Pharmaceutical, 2 Actylis, 8 BASF, 1 Finar, 4 Gangwal Chemicals, 1 Nanjing Bold Chemical, 7 Seppic, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

16 Solubilizers, 12 Topical, 6 Emulsifying Agents, 6 Parenteral, 5 Thickeners and Stabilizers, 4 Film Formers & Plasticizers, 4 Surfactant & Foaming Agents, 2 Direct Compression, 1 Rheology Modifiers, 1 API Stability Enhancers, 1 Lubricants & Glidants, 1 Granulation, 1 Co-Processed Excipients

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

1 Data Compilation #PharmaFlow

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 1 Regulatory FDF Prices

MARKET PLACE

6 APIs

6 APIs

REF. STANDARDS & IMPURITIES

2 EDQM, 3 Others

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
28/03/2025	Johnson & Johnson Innovative Medicine	U.S.A	JANSSEN PHARMACEUTICA NV Beerse BE	R0-CEP 2000-219 - Rev 02	Terconazole	2004-11-16	Withdrawn by Holder	Chemical	2006-07-31	1270
28/03/2025	Nosch Labs Pvt	India	NOSCH LABS PRIVATE LIMITED Hyderabad IN	CEP 2022-298 - Rev 00	Terconazole	2024-11-13	Valid	Chemical		1270

Contact us
to update this info

Zazole

Zazole

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

12 API Suppliers

6 USDMF

2 CEP/COS

1 EU WC

3 NDC API

5 Listed Suppliers

$ API Reference Price

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

12 FDF Dossiers

10 FDA Orange Book

1 Canada

1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;VAGINAL - 0.4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SUPPOSITORY;VAGINAL - 80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;VAGINAL - 0.8% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;VAGINAL - 0.8%

RELATED EXCIPIENT COMPANIES

3 Nanjing Well Pharmaceutical

2 Actylis

8 BASF

1 Finar

4 Gangwal Chemicals

1 Nanjing Bold Chemical

7 Seppic

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

16 Solubilizers

12 Topical

6 Emulsifying Agents

6 Parenteral

5 Thickeners and Stabilizers

4 Film Formers & Plasticizers

4 Surfactant & Foaming Agents

2 Direct Compression

1 Rheology Modifiers

1 API Stability Enhancers

1 Lubricants & Glidants

1 Granulation

1 Co-Processed Excipients

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

1 Regulatory FDF Prices

MARKET PLACE

6 APIs

REF. STANDARDS & IMPURITIES

2 EDQM

3 Others

Filters

CREAM;VAGINAL - 0.4% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SUPPOSITORY;VAGINAL - 80MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CREAM;VAGINAL - 0.8% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons